Immunotherapy has been recognized as one of the most promising therapeutic approaches for improving outcomes in various types of malignant tumors.[25] In this regard, we observed enrichments of RHOA in immune-associated pathways, including antigen processing and presentation, B cell receptor signaling pathway, Toll-like receptor signaling pathway, and more. This evidence concerns the gene RHOA and cancer.